Modulation of asymmetric dimethylarginine in critically ill patients receiving intensive insulin treatment: a possible explanation of reduced morbidity and mortality?

M.P.C. Siroen, P.A.M. van Leeuwsen, R.J. Nijveldt, T. Teerlink, P.J. Wouters, G. van den Berghe

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)504-510
JournalCritical Care Medicine
Issue number3
Publication statusPublished - 2005

Cite this